Ea Pharma Co., Ltd.
Records under this name other than the patents Ea Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,861,575 | Vitamin-Containing Nutrition Infusion for Administration Through Peripheral Vein Formerly held In force · High confidence | In force | High confidence | |
| US 10,709,755 | Solid formulation and method for preventing or reducing coloration thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,420,741 | Megalin Antagonist Formerly held In force · High confidence | In force | High confidence | |
| US 9,883,986 | Standing Bag Type Infusion Liquid Container Formerly held In force · High confidence | In force | High confidence | |
| US 11,844,822 | Solid Formulation and Method for Preventing or Reducing Coloration Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,428,109 | Process for the Preparation of 1,5-Benzothiazepine Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 10,995,115 | Process for the Preparation of 1,5-Benzothiazepine Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,344,589 | Method for Producing a 1,5-Benzothiazepin Compound Formerly held In force · High confidence | In force | High confidence | |
| US 10,039,763 | Pharmaceutical Preparation Comprising Phenylalanine Derivative Lapsed on the fee record Ended Aug 7, 2026 · High confidence | Lapsed on the fee record | Ended Aug 7, 2026 | High confidence |
| US 8,318,975 | Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof Lapsed on the fee record Ended Nov 27, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2024 | From the USPTO record |